• 5-EdU and the New Era of Hypoxia-Driven Tumor Proliferation

  2026-05-01

  This article explores the mechanistic rationale and translational value of 5-Ethynyl-2'-deoxyuridine (5-EdU) for advanced cell proliferation assays in hypoxia-driven tumor models. By integrating new findings on S100A10-mediated chemoresistance in glioblastoma, we offer strategic guidance for researchers aiming to bridge basic discovery with clinical impact. The discussion advances beyond conventional product overviews, highlighting APExBIO's 5-EdU (SKU: B8337) and directly referencing recent literature and workflow assets.

• TRPV1 Antagonist SAF312: Ocular Pharmacology and Toxicology

  2026-05-01

  This study presents a comprehensive preclinical evaluation of SAF312 (Libvatrep), a potent and selective TRPV1 antagonist, for potential topical treatment of ocular surface pain (OSP). The research demonstrates SAF312’s high selectivity, safety, and lack of impairment of corneal wound healing, addressing a critical gap in ocular pain management.

• 20-HETE–TRPV1–MrgprA3+ Axis Drives Allokinesis in Chronic De

  2026-04-30

  This study reveals that the arachidonic acid metabolite 20-HETE activates TRPV1 channels on MrgprA3+ sensory neurons, driving abnormal touch-evoked itch (allokinesis) in chronic dermatitis. By elucidating this neuroimmune pathway, the research highlights new targets for mitigating chronic itch and distinguishes sensory neuron subtypes involved in pain-itch crosstalk.

• HyperPFU™ high-fidelity DNA polymerase: Technical Protocol G

  2026-04-30

  HyperPFU™ high-fidelity DNA polymerase is engineered for PCR amplification of long or GC-rich DNA templates that are difficult for standard enzymes, providing exceptionally accurate and robust results. It is not suitable for protocols requiring 3'-A overhangs or sticky-end products, making it best used in workflows demanding blunt-ended, high-fidelity amplification.

• Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) Research Gu

  2026-04-29

  Angiotensin II (SKU A1042) enables controlled modeling of vasoconstriction, blood pressure regulation, and vascular remodeling in vitro and in vivo. It is best suited for studies of hypertension mechanisms, vascular smooth muscle cell hypertrophy, and abdominal aortic aneurysm models. The product is not appropriate for diagnostic or therapeutic use and requires precise handling to ensure reproducibility.

• Chenodeoxycholic Acid: FXR Activation and Precision in Metab

  2026-04-29

  Explore how Chenodeoxycholic Acid (CDCA) advances metabolic and renal research through its unique FXR-mediated mechanisms. This article offers a deeper look at CDCA's molecular action, protocol optimization, and translational value beyond standard perspectives.

• DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid): App

  2026-04-28

  DIDS empowers advanced chloride channel research in metastasis and neuroprotection with precise, reproducible inhibition profiles. Explore detailed protocols, troubleshooting strategies, and novel workflow enhancements leveraging DIDS from APExBIO for robust results in complex experimental models.

• O-GlcNAcylation Stabilizes OTX2: Mechanisms of Proteostasis

  2026-04-28

  Wulff-Fuentes et al. (2023) elucidate how O-GlcNAcylation at specific serine/threonine residues regulates the stability, solubility, and degradation pathways of the transcription factor OTX2. Their findings advance the understanding of OTX2’s post-translational regulation, with implications for neurodevelopment and cancer biology.

• Sulfo-NHS-SS-Biotin: Practical Guide for Cleavable Biotinyla

  2026-04-27

  Sulfo-NHS-SS-Biotin enables reversible, high-specificity protein labeling and purification by targeting primary amines, especially for cell surface biotinylation without cell penetration. It is not intended for applications requiring intracellular labeling or long-term reagent stability in solution due to its sensitivity to hydrolysis.

• Annexin V-FITC/PI Apoptosis Assay Kit: Advanced Use in Infec

  2026-04-27

  Discover how the Annexin V-FITC/PI Apoptosis Assay Kit enables advanced early apoptosis detection in infection and wound healing models. This guide dives deep into its mechanism, protocol nuances, and the translational impact of apoptosis assays beyond oncology.

• Canagliflozin: Advanced SGLT2 Inhibitor Workflows in Renal R

  2026-04-26

  Canagliflozin, a potent SGLT2 inhibitor from APExBIO, enables not only precise glucose modulation but also unveils new mitochondrial mechanisms in diabetic kidney models. This guide translates the latest bench findings into actionable protocols, troubleshooting, and strategic insights for researchers tackling complex metabolic and renal disease workflows.

• Sabutoclax: Pan-Bcl-2 Inhibitor for Advanced Apoptosis Assay

  2026-04-25

  Sabutoclax stands out among pan-Bcl-2 inhibitors for its multi-target potency, superior cell permeability, and translational value in both in vitro and in vivo cancer models. This guide delivers actionable workflows and troubleshooting tips for maximizing apoptosis induction and assay fidelity, informed by leading-edge research.

• DIDS: Unlocking Chloride Channel Biology for Translational I

  2026-04-24

  This thought-leadership article positions DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid) at the intersection of mechanistic insight and translational strategy. Bridging evidence from recent metastasis research and vascular, neuroprotective, and oncology models, we dissect how precision chloride channel modulation is reshaping experimental designs and therapeutic innovation. The article uniquely integrates rigorous numeric evidence, protocol guidance, and a forward-looking perspective, highlighting the competitive and practical advantages of APExBIO's DIDS for translational researchers.

• GI 254023X: Unleashing Selective ADAM10 Inhibition in Resear

  2026-04-24

  GI 254023X stands out as a highly selective ADAM10 inhibitor, empowering researchers to dissect signaling, barrier integrity, and apoptosis pathways with unparalleled specificity. Its robust workflow compatibility and precision enable reproducible results in vascular, neurodegenerative, and oncology models, setting new standards for translational research.

• Reliable Live-Cell Golgi Imaging with Golgi-Tracker Green

  2026-04-23

  This article provides a scenario-driven, evidence-based guide for biomedical researchers using Golgi-Tracker Green (SKU B8813) in live-cell Golgi apparatus labeling, sphingolipid metabolism analysis, and lipid transport pathway visualization. It details best practices in workflow optimization, probe selection, and data interpretation, highlighting how APExBIO’s formulation offers superior photostability and specificity for reproducible results.

14633 records 1/976 page Next 12345 下5页 Last page